Results 1 to 10 of about 32,153 (233)
Chemical vitiligo: A subset of vitiligo
Indian Journal of Dermatology, 2020 Chemical leucoderma, an under-diagnosed common condition often mimicking idiopathic vitiligo, represents an acquired depigmentation induced by repeated exposure to specific chemical compounds in subjects with genetic susceptibility to vitiligo. This has been increasing rapidly in incidence in recent decades in developing countries like India. The term '
Sanjay Ghosh
openaire +4 more sources
The Journal of Family Practice, 2023 THE COMPARISONA Vitiligo in a young Hispanic female, which spared the area under a ring. The patient has spotty return of pigment on the hand after narrowband ultraviolet B (UVB) treatment.B Vitiligo on the hand in a young Hispanic male.
Uzoamaka, Okoro +2 more
+9 more sources
Anais Brasileiros de Dermatologia, 2004 O vitiligo é doença de pele de causa desconhecida que acomete cerca de 1% da população, comprometendo de modo semelhante homens e mulheres, preferencialmente entre 10 e 30 anos de idade. Alguns fatores precipitantes para essa doença são: estresse físico e emocional, traumas mecânicos e substâncias químicas, como derivados do fenol. Doenças auto-imunes,
Steiner, Denise +4 more
openaire +4 more sources
Nederlands tijdschrift voor geneeskunde, 1997 Vitiligo is a disorder in which, owing to disappearance of melanocytes in the skin, sharply delimited, symmetrically arranged white patches develop. The condition occurs in 1-2% of the population, mostly between the ages of 10 and 30 years, and as often in males as in females. The course is usually progressive with periods of stability.
Njoo, M.D., Westerhof, W.
openaire +5 more sources
Dermatology, 2020 Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of the population worldwide. The disease is characterized by the selective loss of melanocytes which results in typical nonscaly, chalky-white macules. In recent years, considerable progress has been made in our understanding of the pathogenesis of vitiligo which is ...
Bergqvist, Christina, Ezzedine, Khaled
openaire +2 more sources
ISRN Dermatology, 2012 The aim of our study was to determine the epidemiological and clinical aspects of vitiligo in the largest dermatology department of Senegal. A cross-sectional and descriptive study in a period of 5 months was performed covering all the vitiligo cases. Fifty patients were identified (26 women and 24 men). The mean age was 26.5 years. A family history of
Assane Diop +8 more
openaire +2 more sources
Drug–drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450
British Journal of Clinical Pharmacology, EarlyView.Aims To assess the effect of a potent cytochrome P450 (CYP) 3A inhibitor and CYP inducer on the pharmacokinetics of ritlecitinib, a JAK3/TEC family kinase inhibitor, and assess the effect of ritlecitinib on the pharmacokinetics of CYP substrates (midazolam, efavirenz, tolbutamide, caffeine and oral contraceptives [ethinyl oestradiol and levonorgestrel])
Vivek S. Purohit +6 more
wiley +1 more source
Vitiligo and Autoimmunity [PDF]
Medical Archives, 2013 Vitiligo is an acquired skin disorder characterized by depigmented maculae resulting from a reduction of the number and function of melanocytes. The etiopathogenesis of the disease is still unclear, but there is evidence that autoimmunity may be involved.The aim of this study was to determine the prevalence and significance of antinuclear (ANA) and ...
Tomica Jukic +5 more
openaire +2 more sources
Journal of Education, Health and Sport, 2021 Vitiligo is a chronic skin condition which affects 0,5-2% of the world’s population, without any sex or ethnical predilection. Clinically it is characterized by the development of well-defined depigmented macules. Although its etiopathogenesis is exquisitely compound and remains not fully anderstood, it is known that it results from the destruction of ...
Prylińska, Monika +2 more
openaire +3 more sources